Education
About Us
Working with TipRanks
Follow Us
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
Earnings Data
Report Date
Feb 17, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.04Last Year’s EPS
0.06Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted significant achievements, including record product sales growth, improved gross margins, and successful FDA clearances. However, the company faces ongoing challenges with NASDAQ compliance and managing net losses. Overall, the positive aspects of growth and strategic developments outweigh the challenges.Company Guidance
Record Product Sales Growth
NeuroOne Medical Technologies Corporation achieved record product sales growth of 163% to $9.1 million for fiscal year 2025, and a 907% increase in the fourth quarter to $2.7 million.
Improved Gross Margins and Reduced Operating Expenses
Product gross margins improved to 56.5% for the full fiscal year 2025, and operating expenses decreased by 5% for the year.
Successful FDA Clearance and Product Developments
Received FDA 510(k) clearance for the OneRF trigeminal nerve ablation system and advanced development of spinal cord stimulation electrodes for lower back pain.
Successful Capital Raise and Strengthened Financial Position
Raised $8.2 million in capital and ended fiscal year 2025 with $6.6 million in cash and cash equivalents, funding the company through at least fiscal 2026.
Strategic Partnerships and Expansions
Expanded exclusive distribution agreement with Zimmer Biomet and initiated new product development programs for basivertebral nerve ablation.
NMTC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NMTC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Dec 17, 2025 | $0.71 | $0.67 | -5.63% |
Aug 14, 2025 | $0.86 | $0.83 | -3.49% |
May 13, 2025 | $0.62 | $0.64 | +3.23% |
Feb 12, 2025 | $1.09 | $1.12 | +2.75% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does NeuroOne Medical Technologies (NMTC) report earnings?
NeuroOne Medical Technologies (NMTC) is schdueled to report earning on Feb 17, 2026, Before Open (Confirmed).
What is NeuroOne Medical Technologies (NMTC) earnings time?
NeuroOne Medical Technologies (NMTC) earnings time is at Feb 17, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NMTC EPS forecast?
NMTC EPS forecast for the fiscal quarter 2026 (Q1) is -0.04.